David S. Ege
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David S. Ege
David S. Ege is recorded as CTO at Seres Therapeutics, Inc. (MCRB). The proxy statement of Seres Therapeutics, Inc. reports total compensation of $5,318,587 for David S. Ege in fiscal 2020, including a base salary of $76,923.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Seres Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Marella Thorell CEO, CFO, Chief Accounting Officer
- Richard N. Kender CEO, Chairman, Board Member
- Roger J. Pomerantz CEO
- Kelly Brady COO
- Kelly Brady, M.S. COO
- David Arkowitz Chief Accounting Officer
- Eric Shaff Chief Accounting Officer
- Claire Fraser, Ph.D. Board Member
- Claire M. Fraser, Ph.D. Board Member
- Dennis A. Ausiello Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Seres Therapeutics, Inc. (MCRB) | Executive Vice President and Chief Technology Officer | $76,923 | $5,318,587 |
Recent activity
No call appearances or filed executive changes recorded yet.